Search for medicines for human use

Acipimox  •  Cardiovascular system | Lipid modifying agents, plain | Nicotinic acid and derivatives (C10AD06)

Acitretin  •  Dermatologicals | Antipsoriatics for systemic use | Retinoids for treatment of psoriasis (D05BB02)

Aclidinium bromide  •  Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics (R03BB05)

Aclidinium bromide + formoterol fumarate  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids (R03AL05)

Acyclovir  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors (J05AB01)

Acyclovir + hydrocortisone  •  Dermatologicals | Chemotherapeutics for topical use | Antivirals (D06BB53)

Adalimumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors (L04AB04)

Adapalen + benzoyl peroxide  •  Dermatologicals | Anti-acne preparations for topical use | Retinoids for topical use in acne (D10AD53)

Adefovir dipivoxil  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors (J05AF08)

Adenosine  •  Cardiovascular system | Other cardiac preparations (C01EB10)

Adsorbed diphtheria + tetanus vaccine  •  Antiinfectives for systemic use | Bacterial vaccines | Tetanus vaccines (J07AM51)

Adsorbed tetanus vaccine  •  Antiinfectives for systemic use | Bacterial vaccines | Tetanus vaccines (J07AM01)

Adult diphtheria + tetanus vaccine  •  Antiinfectives for systemic use | Bacterial vaccines | Tetanus vaccines (J07AM51)

Adult-type adsorbed diphtheria + tetanus vaccine  •  Antiinfectives for systemic use | Bacterial vaccines | Tetanus vaccines (J07AM51)

Afatinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (L01EB03)

Aflibercept  •  Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents (S01LA05)

Agomelatine  •  Nervous system | Antidepressants | Other antidepressants (N06AX22)

Alanyl-glutamine  •  Blood and blood forming organs | I.v. solution additives | Amino acids (B05XB02)

Albendazole  •  Antiparasitic products, insecticides and repellents | Antinematodal agents | Benzimidazole derivatives (P02CA03)

Albumin  •  Blood and blood forming organs | Blood and related products | Blood substitutes and plasma protein fractions (B05AA01)

Alclometasone  •  Dermatologicals | Corticosteroids, plain | Corticosteroids, moderately potent (group ii) (D07AB10)

Alectinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Anaplastic lymphoma kinase (ALK) inhibitors (L01ED03)

Alemtuzumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants (L04AA34)

Alendronic acid  •  Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates (M05BA04)

Alendronic acid + calcium + cholecalciferol  •  Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates, combinations (M05BB05)

Alendronic acid + cholecalciferol  •  Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates, combinations (M05BB03)

Alfacalcidol  •  Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues (A11CC03)

Alfuzosin  •  Genito urinary system and sex hormones | Drugs used in benign prostatic hypertrophy | Alpha-adrenoreceptor antagonists (G04CA01)

Alirocumab  •  Cardiovascular system | Lipid modifying agents, plain | Other lipid modifying agents (C10AX14)

Aliskiren  •  Cardiovascular system | Other agents acting on the renin-angiotensin system | Renin-inhibitors (C09XA02)